L. Lopez Manzanares - Hospital Universitario La Princesa Madrid

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 58 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Continuous subcutaneous levodopa/carbidopa infusion (ND0612) for patients with Parkinson’s disease and motor fluctuations: A Phase 3, active-controlled study (BouNDless)

F. Stocchi,A. Espay,A. Albanese,A. Ellenbogen,J.J. Ferreira,N. Giladi,T. Gurevich,S. Hassin-Baer,J. Hernandez-Vara,S. Isaacson,K. Kieburtz,P. LeWitt,

Parkinsonism & Related Disorders (2024)

引用0浏览0引用

Continuity and presence of side effects of continuous subcutaneous apomorphine infusion and levodopa-carbidopa intestinal gel infusion in advanced Parkinson's disease, in a movement disorder unit in Spain

I. Muro Garcia,J. Alonso Maroto,B. Gonzalez Garcia, E. Carabajal Pendon,E. Casas,L. Lopez Manzanares

MOVEMENT DISORDERS (2023): S616-S617

引用0浏览0引用

Changes in principal caregiver mood affects the mood of the Parkinson disease patient. The vicious cycle of illness

D. Santos,T. De Deus Fonticoba,S. Jesus,M. Buongiorno,L. Planellas,M. Cosgaya,J. Garcia Caldentey,N. Caballol,I. Legarda,J. Hernandez-Vara,I. Cabo,L. Lopez Manzanares,

J Parkinsons Dis（2023）

引用1浏览0WOS引用

Teleprogramming Reduces the Time Needed to Optimize DBS Therapy: Results from the ROAM-DBS study

A. Gharabaghi, D. Weiss,S. Groppa,L. Lopez Manzanares,A. Schnitzler, R. Alvarez, L. Munoz-Delgado,C. Luca, J. Karl, V. Marshall, L. Zhang, M. Soileau,

MOVEMENT DISORDERS (2023): S779-S779

引用0浏览0引用

Early-Onset Cortico-Basal Degeneration (CBD) Due To A C.2092G>A MAPT Mutation

M. Mata Alvarez-Santullano,L. Lopez-Manzanares, J. Lopez-Lozano, N. Villares, C. Magdaleno, C. Dela Torre

MOVEMENT DISORDERS (2023): S96-S96

引用0浏览0引用

Non-motor symptoms progression in Parkinsons disease. A 4-year follow-up study

D. Santos,T. de Deus, C. Cores,M. Feal Painceiras, I. Garcia-Diaz,M. Iniguez,J. Paz Gonzalez,S. Jesus,M. Cosgaya,J. Garcia Caldentey,N. Caballol,I. Legarda,

MOVEMENT DISORDERS (2023): S215-S217

引用0浏览0引用

Enrolment characteristics for patients entering a Phase 3 study of subcutaneous levodopa/carbidopa infusion with ND0612

O. Rascol,A. Albanese,A. Ellenbogen,J. Ferreira,T. Gurevich, S. Hassin,J. Hernandez-Vara,S. Isaacson,K. Kieburtz,P. LeWitt,L. Lopez Manzanares,C. Olanow,

EUROPEAN JOURNAL OF NEUROLOGY (2023): 708-709

引用0浏览0引用

Continuous Subcutaneous Levodopa/Carbidopa Infusion With ND0612 For Patients With Parkinson's Disease And Motor Fluctuations: Results From The Phase 3 Randomized, Active-Controlled BouNDless Study

O. Rascol,A. Albanese,A. Ellenbogen,J. Ferreira,N. Giladi,T. Gurevich,S. Hassin-Baer,J. Hernandez-Vara,S. Isaacson,K. Kieburtz,P. LeWitt,L. Lopez-Manzanares,

MOVEMENT DISORDERS (2023): S4-S4

引用0浏览0引用

A pilot study to prepare patients for doctor's consultation based on the NMS-Quest and a wearable medical device

D. Rodriguez-Martin, L. Carrasco, D. Alvarez, M. Perez, C. Capra,M. Mata,M. Kurtis,C. Borrue,L. Lopez-Manzanares

MOVEMENT DISORDERS (2023): S792-S793

引用0浏览0引用

Dyskinesia Signs and Symptoms, and Quality of Life in Parkinson's Disease: Post Hoc Analysis From the DYSCOVER Study

E. Freire Alvarez,P. Vanni,E. Kurca,L. Lopez Manzanares,N. Kovacs,C. Spanaki,T. Gao, L. Bergmann,O. Sanchez-Solino,L. Barbato

EUROPEAN JOURNAL OF NEUROLOGY（2022）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn